Successful Treatment of Vancomycin-Resistant Enterococcus faecium Bacteremia with Linezolid after Failure of Treatment with Synercid (Quinupristin/Dalfopristin)

This publication has 11 references indexed in Scilit:

• Successful Treatment of Persistent Vancomycin‐Resistant Enterococcus faecium Bacteremia with Linezolid and Gentamicin
  Clinical Infectious Diseases, 1999
• Treatment of Vancomycin-Resistant Enterococcus faecium with RP 59500 (Quinupristin-Dalfopristin) Administered by Intermittent or Continuous Infusion, Alone or in Combination with Doxycycline, in an In Vitro Pharmacodynamic Infection Model with Simulated Endocardial Vegetations
  Antimicrobial Agents and Chemotherapy, 1998
• Comparative In Vitro Activities and Postantibiotic Effects of the Oxazolidinone Compounds Eperezolid (PNU-100592) and Linezolid (PNU-100766) versus Vancomycin against Staphylococcus aureus , Coagulase-Negative Staphylococci, Enterococcus faecalis , and Enterococcus faecium
  Antimicrobial Agents and Chemotherapy, 1998
• Comparative In Vitro and Bactericidal Activity of Oxazolidinone Antibiotics Against Multidrug-Resistant Enterococci
  Diagnostic Microbiology and Infectious Disease, 1998
• Vancomycin-resistant enterococci: Clinical, microbiologic, and epidemiologic features
  Journal of Laboratory and Clinical Medicine, 1997
• Therapy with RP 59500 (quinupristin/dalfopristin) for prosthetic valve endocarditis due to enterococci with VanA/VanB resistance patterns.
  Clinical Infectious Diseases, 1997
• Comparative in vitro activity of quinupristin/dalfopristin against multidrug resistant Enterococcus faecium
  Diagnostic Microbiology and Infectious Disease, 1996
• In vitro activities in new oxazolidinone antimicrobial agents against enterococci
  Antimicrobial Agents and Chemotherapy, 1996
• Antibacterial Activity of Quinupristin/Dalfopristin
  Drugs, 1996